AMX0035 in Adult Patients With Wolfram Syndrome
Clinical trial NCT05676034 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05676034
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2024-07-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.